F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome

Journal of Lipid Research

Volumn 52, Issue 12, 2011, Pages 2287-2297

  De Felice, Claudio ^a   Signorini, Cinzia ^b   Durand, Thierry ^c   Oger, Camille ^c   Guy, Alexandre ^c   Bultel Poncé, Valérie ^c   Galano, Jean Marie ^c   Ciccoli, Lucia ^b   Leoncini, Silvia ^b   D'Esposito, Maurizio ^d,e   Filosa, Stefania ^d,e   Pecorelli, Alessandra ^b   Valacchi, Giuseppe ^f,g   Hayek, Joussef ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^e IRCCS NEUROMED   (Italy)

^f UNIVERSITY OF FERRARA   (Italy)

^g Kyung Hee University   (South Korea)

Author keywords

Adrenic acid; Autism spectrum disorders; Methyl CpG binding protein 2; Myelin damage

Indexed keywords

ADRENIC ACID; BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; METHYL CPG BINDING PROTEIN 2; MYELIN; ERUCIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GAS CHROMATOGRAPHY; GENE; GENE MUTATION; HUMAN; INFANT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MECP2 GENE; OXIDATIVE STRESS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETT SYNDROME; SCHOOL CHILD; TANDEM MASS SPECTROMETRY; ANTIBODY SPECIFICITY; BLOOD; CHEMISTRY; METABOLISM; MYELIN SHEATH;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ERUCIC ACIDS; F2-ISOPROSTANES; FEMALE; HUMANS; INFANT; LIPID PEROXIDATION; MYELIN SHEATH; ORGAN SPECIFICITY; OXIDATIVE STRESS; RETT SYNDROME; YOUNG ADULT;

EID: 81855217494     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P017798     Document Type: Article

References (55)

1. Amir, R. E., I. B. Van den Veyver, M. Wan, C. Q. Tran, U. Francke, and H. Y. Zoghbi. 1999. Rett syndrome is caused by mutation in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23: 185-188. (Pubitemid 29455390)
2. Cardaioli, E., M. T. Dotti, G. Hayek, M. Zappella, and A. Federico. 1999. Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835. J. Submicrosc. Cytol. Pathol. 31: 301-304. (Pubitemid 129553505)
3. Squillaro, T., G. Hayek, E. Farina, M. Cipollaro, A. Renieri, and U. Galderisi. 2008. A case report: bone marrow mesenchymal stem cells from a Rett syndrome patient are prone to senescence and show a lower degree of apoptosis. J. Cell. Biochem. 103: 1877-1885. (Pubitemid 351501918)
4. De Felice, C., G. Guazzi, M. Rossi, L. Ciccoli, C. Signorini, S. Leoncini, G. Tonni, G. Latini, G. Valacchi, and J. Hayek. 2010. Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study. Chest. 138: 386-392.
5. Guideri, F., M. Acampa, T. DiPerri, M. Zappella, and Y. Hayek. 2001. Progressive cardiac dysautonomia observed in patients affected by classic Rett syndrome and not in the preserved speech variant. J. Child Neurol. 16: 370-373. (Pubitemid 32547304)
6. Weng, S. M., F. McLeod, M. E. Bailey, and S. R. Cobb. 2011. Synaptic plasticity deficits in an experimental model of Rett syndrome: long-term potentiation saturation and its pharmacological reversal. Neuroscience. 180: 314-321.
7. Armstrong, D., J. K. Dunn, B. Antalffy, and R. Trivedi. 1995. Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54: 195-201.
8. Belichenko, P. V., B. Hagberg, and A. Dahlstrom. 1997. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol. 93: 50-61. (Pubitemid 127471347)
9. Armstrong, D. D., K. Dunn, and B. Antalffy. 1998. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol. 57: 1013-1017. (Pubitemid 28525447)
10. Armstrong, D. D. 2005. Can we relate MeCP2 deficiency to the structural and chemical abnormalities in the Rett brain? Brain Dev. 27 (Suppl.): 72-76.
11. Chao, H. T., H. Y. Zoghbi, and C. Rosenmund. 2007. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron. 56: 58-65. (Pubitemid 47484176)
12. Zhang, L., J. He, D. G. Jugloff, and J. H. Eubanks. 2008. The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus. 18: 294-309. (Pubitemid 351399632)
13. D'Cruz, J. A., C. Wu, T. Zahid, Y. El-Hayek, L. Zhang, and J. H. Eubanks. 2010. Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice. Neurobiol. Dis. 38: 8-16.
14. Guy, J., J. Gan, J. Selfridge, S. Cobb, and A. Bird. 2007. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 315: 1143-1147. (Pubitemid 46328028)
15. Mahmood, A., G. Bibat, A. L. Zhan, I. Izbudak, L. Farage, A. Horska, S. Mori, and S. Naidu. 2010. White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations. Am. J. Neuroradiol. 31: 295-299.
16. De Felice, C., L. Ciccoli, S. Leoncini, C. Signorini, M. Rossi, L. Vannuccini, G. Guazzi, G. Latini, M. Comporti, G. Valacchi, et al. 2009. Systemic oxidative stress in classic Rett syndrome. Free Radic. Biol. Med. 47: 440-448.
17. Sastry, P. S. 1985. Lipids of nervous tissue: composition and metabolism. Prog. Lipid Res. 24: 69-176.
18. VanRollins, M., R. L. Woltjer, H. Yin, J. D. Morrow, and T. J. Montine. 2008. F2-dihomo-isoprostanes arise from free radical attack on adrenic acid. J. Lipid Res. 49: 995-1005.
19. Sprecher, H., M. VanRollins, F. Sun, A. Wyche, and P. Needleman. 1982. Dihomo-prostaglandins and -thromboxane. A prostaglandin family from adrenic acid that may be preferentially synthesized in the kidney. J. Biol. Chem. 257: 3912-3918.
20. Oger, C., Y. Brinkmann, S. Bouazzoui, T. Durand, and J-M. Galano. 2008. Stereocontrolled access to isoprostanes via a bicyclo[3.3.0] octene framework. Org. Lett. 10: 5087-5090.
21. Neul, J. L., W. E. Kaufmann, D. G. Glaze, J. Christodoulou, A. J. Clarke, N. Bahi-Buisson, H. Leonard, M. E. Bailey, N. C. Schanen, M. Zappella, et al. 2010. Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68: 944-950.
22. Christodoulou, J., A. Grimm, T. Maher, and B. Bennetts. 2003. RettBASE: the IRSA MECP2 variation database - a new mutation database in evolution. Hum. Mutat. 21: 466-472.
23. Sampieri, K., I. Meloni, E. Scala, F. Ariani, R. Caselli, C. Pescucci, I. Longo, R. Artuso, M. Bruttini, M. A. Mencarelli, et al. 2007. Italian Rett database and biobank. Hum. Mutat. 28: 329-335. (Pubitemid 46542919)
24. Hagberg, B. 2002. Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8: 61-65. (Pubitemid 34606514)
25. Neul, J. L., P. Fang, J. Barrish, J. Lane, E. B. Caeg, E. O. Smith, H. Zoghbi, A. Percy, and D. G. Glaze. 2008. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology. 70: 1313-1321. (Pubitemid 351550354)
26. Monrós, E., J. Armstrong, E. Aibar, P. Poo, I. Canós, and M. Pineda. 2001. Rett syndrome in Spain: mutation analysis and clinical correlations. Brain Dev. 23 (Suppl. 1): 251-253.
27. Oger, C., S. Marton, Y. Brinkmann, V. Bultel-Poncé, T. Durand, M. Grabber, and J-M. Galano. 2010. Lipase-catalyzed regioselective monoacetylation of unsymmetrical 1,5-primary diols. J. Org. Chem. 75: 1892-1897.
28. Asha Devi, S., C. S. Shiva Shankar Reddy, and M. V. Subramanyam. 2011. Peroxyl-induced oxidative stress in aging erythrocytes of rat. Biogerontology. 12: 283-292.
29. Tomida, H., T. Fujii, N. Furutani, A. Michihara, T. Yasufuku, K. Akasaki, T. Maruyama, M. Otagiri, J. M. Gebicki, and M. Anraku. 2009. Antioxidant properties of some different molecular weight chitosans. Carbohydr. Res. 344: 1690-1696.
30. Signorini, C., M. Comporti, and G. Giorgi. 2003. Ion trap tandem mass spectrometric determination of F2-isoprostanes. J. Mass Spectrom. 38: 1067-1074. (Pubitemid 37407701)
31. Waugh, R. J., J. D. Morrow, L. J. Roberts II, and R. C. Murphy. 1997. Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat. Free Radic. Biol. Med. 23: 943-954. (Pubitemid 27402620)
32. Li, H., J. A. Lawson, M. Reilly, M. Adiyaman, S. W. Hwang, J. Rokach, and G. A. FitzGerald. 1999. Quantitative high performance liquid chromatography tandem/mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc. Natl. Acad. Sci. USA. 96: 13381-13386.
33. Yin, H., E. S. Musiek, L. Gao, N. A. Porter, and J. D. Morrow. 2005. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J. Biol. Chem. 280: 26600-26611. (Pubitemid 41022258)
34. Tanabe, H., T. Sawada, N. Inoue, M. Ogawa, Y. Kuriyama, and J. Shiraishi. 1987. Conduction aphasia and arcuate fasciculus. Acta Neurol. Scand. 76: 422-427. (Pubitemid 18016520)
35. Boatman, D., B. Gordon, J. Hart, O. Selnes, D. Miglioretti, and F. Lenz. 2000. Transcortical sensory aphasia: revisited and revised. Brain. 123: 1634-1642. (Pubitemid 30481187)
36. Pan, J. W., J. B. Lane, H. Hetherington, and A. K. Percy. 1999. Rett syndrome: 1H spectroscopic imaging at 4.1 Tesla. J. Child Neurol. 14: 524-528. (Pubitemid 29394952)
37. Cappa, M., C. Bizzarri, C. Vollono, A. Petroni, and S. Banni. 2011. Adrenoleukodystrophy. Endocr. Dev. 20: 149-160.
38. Saunders, K. J., D. L. McCulloch, and A. M. Kerr. 1995. Visual function in Rett syndrome. Dev. Med. Child Neurol. 37: 496-504.
39. Deoni, S. C., E. Mercure, A. Blasi, D. Gasston, A. Thomson, M. Johnson, S. C. Williams, and D. G. Murphy. 2011. Mapping infant brain myelination with magnetic resonance imaging. J. Neurosci. 31: 784-791.
40. Yakovlev, P. I., and A. R. Leours. 1967. The myelogenetic cycles of regional maturation of the brain. In Regional Development of the Brain in Early Life. A. Minkowski, editor. Blackwell, Oxford. 3-70.
41. Kinney, H. C., B. A. Brody, A. S. Kloman, and F. H. Gilles. 1988. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J. Neuropathol. Exp. Neurol. 47: 217-234.
42. Einspieler, C., A. M. Kerr, and H. F. Prechtl. 2005. Abnormal general movements in girls with Rett disorder: the first four months of life. Brain Dev. 27 (Suppl.): 8-13.
43. Einspieler, C., A. M. Kerr, and H. F. Prechtl. 2005. Is the early development of girls with Rett disorder really normal? Pediatr. Res. 57: 696-700. (Pubitemid 40578041)
44. Calfa, G., A. K. Percy, and L. Pozzo-Miller. 2011. Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp. Biol. Med. (Maywood). 236: 3-19.
45. Cobb, S., J. Guy, and A. Bird. 2010. Reversibility of functional defi- cits in experimental models of Rett syndrome. Biochem. Soc. Trans. 38: 498-506.
46. Lintas, C., R. Sacco, and A. M. Persico. 2011. Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol. Dis. In press.
47. Balagopalakrishna, C., P. T. Manoharan, O. O. Abugo, and J. M. Rifkind. 1996. Production of superoxide from hemoglobin-bound oxygen under hypoxic conditions. Biochemistry. 35: 6393-6398. (Pubitemid 26164073)
48. Nagababu, E., S. Ramasamy, and J. M. Rifkind. 2002. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry. 41: 7407-7415. (Pubitemid 34602459)
49. Ciccoli, L., V. Rossi, S. Leoncini, C. Signorini, J. Blanco-Garcia, C. Aldinucci, G. Buonocore, and M. Comporti. 2004. Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation. Biochim. Biophys. Acta. 1672: 203-213.
50. Wang, H., G. Yuan, N. R. Prabhakar, M. Boswell, and D. M. Katz. 2006. Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling. J. Neurochem. 96: 694-705.
51. Pugazhenthi, S., K. Phansalkar, G. Audesirk, A. West, and L. Cabell. 2006. Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic. Biol. Med. 40: 21-34. (Pubitemid 41759400)
52. Urdinguio, R. G., L. Lopez-Serra, P. Lopez-Nieva, M. Alaminos, R. Diaz-Uriarte, A. F. Fernandez, and M. Esteller. 2008. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS ONE. 3: e3669.
53. Kriaucionis, S., A. Paterson, J. Curtis, J. Guy, N. Macleod, and A. Bird. 2006. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol. Cell. Biol. 26: 5033-5042. (Pubitemid 43955817)
54. Pecorelli, A., L. Ciccoli, C. Signorini, S. Leoncini, A. Giardini, M. D'Esposito, S. Filosa, J. Hayek, C. De Felice, and G. Valacchi. 2011. Increased levels of 4HNE-protein plasma adducts in Rett syndrome. Clin. Biochem. 44: 368-371.
55. Signorini, C., C. De Felice, S. Leoncini, A. Giardini, M. D'Esposito, S. Filosa, F. Della Ragione, M. Rossi, A. Pecorelli, G. Valacchi, et al. 2011. F(4)-neuroprostanes mediate neurological severity in Rett syndrome. Clin. Chim. Acta. 412: 1399-1406.